Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 14, 2015 - Issue 7
Submit an article Journal homepage
401
Views
2
CrossRef citations to date
0
Altmetric
Drug Safety Evaluation

A critical appraisal of daclizumab use as emerging therapy in multiple sclerosis

Emanuele D’AmicoRKU - Universitäts- und Rehabilitationskliniken Ulm, Oberer Eselsberg 45, 89081 Ulm, Germany
, MD,
Silvia MessinaCentro Sclerosi Multipla, Dipartimento di Neurologia, via Santa Sofia, 78 Catania, Italy
, MD,
Cinzia CasertaCentro Sclerosi Multipla, Dipartimento di Neurologia, via Santa Sofia, 78 Catania, Italy
, BSc &
Francesco PattiUniversita´degli Studi di Catania, Dipartimento di Neurologia, via Santa Sofia, 78 Catania, [email protected]
, MD (Associate Professor)
Pages 1157-1168 | Published online: 31 Mar 2015

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Emanuele D’Amico, Aurora Zanghì & Francesco Patti. (2017) Can new chemical therapies improve the management of multiple sclerosis in children?. Expert Opinion on Pharmacotherapy 18:1, pages 45-55.
Read now

Articles from other publishers (1)

Regina Berkovich, Rohit Bakshi, Lilyana Amezcua, Robert C. Axtell, Steven Y. Cen, Shahamat Tauhid, Mohit Neema & Lawrence Steinman. (2016) Adrenocorticotropic hormone versus methylprednisolone added to interferon β in patients with multiple sclerosis experiencing breakthrough disease: a randomized, rater-blinded trial . Therapeutic Advances in Neurological Disorders 10:1, pages 3-17.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.